The global incidence of chronic and acute respiratory illnesses, including COPD, bronchitis, and pneumonia, continues to place a substantial burden on healthcare systems worldwide. This persistent challenge serves as a bedrock for the stability and growth of the N-Acetylcysteine (NAC) market. NAC’s fundamental efficacy as a mucolytic agent—helping to thin and loosen bronchial...